A Study of Carbon-14-Labelled [14C] LY3556050 in Healthy Male Participants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
The main purpose of this study is to evaluate how much of the study drug (LY3556050), administered as a single dose that has the radioactive substance 14C incorporated into it, passes from blood into urine, feces and expired air in healthy male participants. The study will also measure how much of the study drug gets into the bloodstream, how its broken down, and how long it takes the body to get rid of it. The study will last up to approximately 58 days including the screening period.
Epistemonikos ID: 3aa68313aa0fc5b514f4ce7eaf4941b9459efdd5
First added on: May 15, 2024